Investing Ideas
/
Swiss Pharmaceuticals & Biotech Dividend Powerhouses (3%+ Yield)

Swiss Pharmaceuticals & Biotech Dividend Powerhouses (3%+ Yield)

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

This screener pinpoints dividend all-stars that boast strong fundamentals with yields typically exceeding 3%.

1 companies

Novartis

Market Cap: CHF 168.4b

Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.

NOVN

CHF 88.74

1.9%

2.6%